enkephalin, leucine has been researched along with hmr 1098 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bissessar, E; Bobrova, I; Gross, GJ; Hsu, A; Nithipatikom, K; Pfeiffer, AW | 1 |
1 other study(ies) available for enkephalin, leucine and hmr 1098
Article | Year |
---|---|
Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels.
Topics: Animals; Benzamides; Cardiotonic Agents; Decanoic Acids; Enkephalins; Hydroxy Acids; KATP Channels; Male; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu | 2012 |